- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: empagliflozin
Total 435 results
-
McGill UniversityCompleted
-
University Hospital TuebingenActive, not recruiting
-
Caroline M KistorpRigshospitalet, Denmark; Herlev and Gentofte Hospital; Danish Heart FoundationCompletedType2 Diabetes MellitusDenmark
-
Ananda Basu, MDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaboratorsCompletedType 1 DiabetesUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
National Institute on Aging (NIA)CompletedPhysiological Effects of Drugs | Hypoglycemic Agents | Empaglifozin | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Chungbuk National University HospitalActive, not recruitingDiabetes Mellitus, Type 2
-
Chungbuk National University HospitalCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Italy, Poland, Russian Federation, Spain, Greece, Serbia, Thailand, Brazil, Hungary, Argentina
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Denmark, Canada, Belgium, China, Italy, Germany, Spain, Netherlands, Hungary, Japan, Norway, Poland, Sweden, Czechia
-
Khoo Teck Puat HospitalCompletedType II Diabetes in Subjects BMI 27 to 32Singapore
-
Samuel Lunenfeld Research Institute, Mount Sinai...McGill University Health Centre/Research Institute of the McGill University...Completed
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Korea, Republic of, China, Germany, Belgium, Australia, Singapore, Canada, Italy, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, United Kingdom, Mexico, Romania, Brazil, India, South Africa, Colombia
-
Boehringer IngelheimWithdrawnCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
Medical University of GrazMedical University of Vienna; Johannes Kepler University of Linz; Paracelsus... and other collaboratorsCompletedAcute Myocardial InfarctionAustria
-
Getz PharmaCompleted
-
Sadat City UniversityBeni-Suef UniversityCompleted
-
SanofiCompleted
-
Kasr El Aini HospitalCompleted
-
Brigham and Women's HospitalPatient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...Active, not recruitingType2 Diabetes | Renal Disease | Cardiovascular EventsUnited States
-
Boehringer IngelheimCompleted
-
Mutah UniversityCompletedPharmacokinetic ParametersJordan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
-
Alexandria UniversityEva PharmaActive, not recruitingDiabetes Mellitus, Type 2 | Fatty Liver, NonalcoholicEgypt
-
M.H.H. KramerActive, not recruitingType2 DiabetesNetherlands
-
National Medical Research Center for Cardiology...Ministry of Health of the Russian FederationCompletedDiabetes Mellitus, Type 2 | Heart Failure, DiastolicRussian Federation
-
University Hospital, Basel, SwitzerlandCompletedHyponatremia | SIAD - Syndrome of Inappropriate AntidiuresisSwitzerland
-
Saint Luke's Health SystemCompletedHeart FailureUnited States
-
Genuine Research Center, EgyptHikma PharmaCompleted
-
Centro Universitario de Ciencias de la Salud, MexicoActive, not recruitingDiabetes Mellitus Type 2 Without ComplicationMexico
-
Handok Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
Amsterdam UMC, location VUmcWithdrawnDiabetes Mellitus, Type 2 | Chronic Kidney Diseases
-
Amsterdam UMC, location VUmcCompletedDiabetes Mellitus, Type 2 | Diabetic Kidney DiseaseNetherlands
-
Roswell Park Cancer InstituteCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma and other conditionsUnited States
-
Research Institute for Complex Problems of Cardiovascular...CompletedCoronary Artery Disease | Diabetes Mellitus | Percutaneous Coronary Intervention
-
University of PisaCompletedEnd Stage Renal DiseaseItaly
-
Mario Negri Institute for Pharmacological ResearchBoehringer IngelheimWithdrawnObesity | Non-diabetic Chronic Kidney Disease
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Christian SchulzeBoehringer Ingelheim; Zentrum für Klinische Studien JenaCompletedAcute Decompensated Heart FailureGermany
-
Boehringer IngelheimCompleted
-
University of DundeeBritish Heart FoundationCompletedHeart Failure | Type 2 Diabetes MellitusUnited Kingdom
-
Samuel Lunenfeld Research Institute, Mount Sinai...McGill University Health Centre/Research Institute of the McGill University... and other collaboratorsCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited Kingdom
-
Henrik Enghusen PoulsenUniversity of Copenhagen; University Hospital, Gentofte, CopenhagenCompletedDiabetes Mellitus, Type 2Denmark
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Metacrine, Inc.Active, not recruitingDiabetes | Fatty Liver | Type 2 Diabetes | NAFLD | NASH - Nonalcoholic Steatohepatitis | Diabetes Type 2 | NASH | Fatty Liver, NonalcoholicUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Korea, Republic of, China, Germany, Belgium, Australia, Italy, United Kingdom, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, Mexico, India, Brazil, France